Tuesday, October 25, 2022 5:17:20 PM
1. IGEX is looking to list on the Frankfurt stock exchange. Mentioned 88 days ago (July 27).
2. Want OTCQB status - mentioned July 27.
3. Mentioned 89 days ago that IGEX is now clean, structured and in good order.
4. On May 20th the 1st Merger was confirmed but has yet to be announced.
5. April 19 CEO guarantees a Reverse Split will not occur.
6. October 20 the Annual Report was filed which showed no change in OS share structure. It has remained the same for several months.
7. The Annual Report 5 days ago reported the following The regarding IGEX:
“The Mineral Company Ltd. (INDO Global Exchange(s) Ltd.) has acquired a 50,000 SQM (or 538,196 sq. ft.), located in Jumilla, Spain for a total of EUR $300,000.00 plus approximately an 11% tax assessment. Remarkably, the property is worth UR980M as shown by the independent appraisal performed by “Arquitasa” (Sociedad de Tasación), which has been homologated by “Banco de España.” (See exhibits in 8K). The transaction was financed by the Seller, in a 7-year term loan at 2% per annum, guaranteed by one of Igex Preferred Shareholders. The Source of repayment will come from revenues generated.
The lot is set to become the premier and biggest center in Southern Europe for storage, shipping, and development of minerals; particularly focusing on lithium and graphene, its applications and derivatives. Engineers and architects are already retained to work on all necessary plans and permits with the goal to break ground in less than 6 months aiming at having the first phase of the project completed and operational by year-end 2022. The lot(s) are located in an approved "urban" zone, thus not requiring rezoning applications. The construction of the center is permitted under the current zoning as shown in the attached exhibits. A new 8-K form will be filed and released soon in relation to a new acquisition and subsequent merger.”
Recent IGEX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:09:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM